home / stock / nktx / nktx short
Short Information | Nkarta Inc. (NASDAQ:NKTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,076,280 |
Total Actual Volume | 21,131,302 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 153,814 |
Average Short Percentage | 16.65% |
Is there a NKTX Short Squeeze or Breakout about to happen?
See the NKTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $6.68 | $6.21 | $6.68 | $6.135 | 745,859 | 183,677 | 24.63% |
07-18-2024 | $7.54 | $6.65 | $7.55 | $6.33 | 1,058,046 | 223,978 | 21.17% |
07-17-2024 | $7.74 | $7.57 | $8 | $7.46 | 940,140 | 182,890 | 19.45% |
07-16-2024 | $7.28 | $8 | $8.23 | $7.05 | 2,774,039 | 459,018 | 16.55% |
07-15-2024 | $6.56 | $7.02 | $7.24 | $6.53 | 972,528 | 162,475 | 16.71% |
07-12-2024 | $6.68 | $6.51 | $6.97 | $6.4 | 1,008,355 | 115,531 | 11.46% |
07-11-2024 | $5.56 | $6.465 | $6.56 | $5.56 | 1,031,832 | 142,660 | 13.83% |
07-10-2024 | $5.72 | $5.48 | $5.74 | $5.4 | 510,043 | 119,770 | 23.48% |
07-09-2024 | $5.28 | $5.72 | $5.73 | $5.16 | 623,645 | 119,716 | 19.2% |
07-08-2024 | $5.27 | $5.3 | $5.48 | $5.16 | 567,452 | 87,809 | 15.47% |
07-05-2024 | $5.33 | $5.18 | $5.34 | $5.115 | 361,699 | 88,614 | 24.5% |
07-03-2024 | $5.26 | $5.355 | $5.5866 | $5.14 | 232,697 | 34,147 | 14.67% |
07-02-2024 | $5.78 | $5.26 | $5.89 | $5.245 | 564,510 | 101,906 | 18.05% |
07-01-2024 | $5.9 | $5.85 | $6.11 | $5.78 | 608,759 | 107,012 | 17.58% |
06-28-2024 | $5.91 | $5.91 | $5.96 | $5.63 | 4,008,557 | 252,605 | 6.3% |
06-27-2024 | $5.97 | $5.86 | $6.12 | $5.63 | 882,364 | 155,565 | 17.63% |
06-26-2024 | $6.09 | $5.97 | $6.09 | $5.74 | 988,767 | 171,962 | 17.39% |
06-25-2024 | $5.57 | $6.13 | $6.15 | $5.52 | 950,342 | 165,865 | 17.45% |
06-24-2024 | $5.55 | $5.6 | $5.66 | $5.33 | 1,080,596 | 99,497 | 9.21% |
06-21-2024 | $5.34 | $5.5 | $5.52 | $5.05 | 1,221,072 | 101,583 | 8.32% |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced changes to its leadership team. Nadir Mahmood, Ph.D., will join Nkarta as President this month, sharing...
Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of lupus nephritis IND cleared for Ntrust-2, a clinical trial for NKX019 for the treatment of systemic sclerosis, myositis and vasculitis Clinical data ...